Reduction of the nitroso group in streptozotocin (1a) has led to cyclized products rather than a semicarbazide (1c). Some analogs (le, 9a, 9b, 9c and 9d) of streptozotocin in which the nitroso group was replaced by other groups have been prepared. Streptozotocin (1a) is an antibiotic having antibacterial" and antileukemic2I activity and activity against malignant insulinomas.3' Because of the interesting biological properties of streptozotocin and the relative simplicity of its structure-'' a number of analogs have been prepared varying in the carbohydrate moiety, in the position of the nitrosourea group, in the N-3 alkyl group and in groups attached to the streptozotocin hydroxyl groups. However, all compounds having two substituents on N-3 retained the nitroso group. It appeared to be of interest to prepare analogs of streptozotocin in which the nitroso group would be replaced by other groups, preferably electron-rich group such as NO, (Ib) but with no other changes.
The first approach to analog synthesis was the reduction of the NO group in la in an attempt to prepare lc. Treatment of streptozotocin with hydrogen under low pressure using either Pd-C or PdBaSOi catalyst gave a mixture of two products as indicated by tlc and an NMR spectrum which exhibited two resonances attributable to CH3N groups. Crystallization of the amorphous mixture from alcohol usually led to a material (2a) which had been reported previously by HERR et al. 10i The identity was established by mp, ir, NMR, rotation and elemental analysis. However, in one experiment a second product (2b) was isolated. Slow evaporation of an aqueous solution of 2b to a crystalline residue converted it to 2a. A high resolution mass spectrum of 2b established that it is isomeric with 2a.
The it spectrum of 2b shows functional groups similar to those in 2a and combined with the ready conversion of 2b to 2a and the same composition suggests that the two compounds differ only in configuration at C-l. Structure 2 has been assigned to 2a with no discussion of configuration at C-1.'0' Although the chemical shifts of the anomeric protons in 2a and 2b suggest the a and /3 configurations, respectively, the coupling constants of these protons indicate the reverse configurations.") BUNDLE and his coworkers") have reported the 13C NMR spectra of the a and /3 isomers of methyl 2-deoxy-2-acetamide-f-D-glucopyranoside. Since the 13C NMR spectrum of 2a much more closely resembles that of the fl-isomer, especially at C-3 and C-5 which give the significantly different chemical shifts in the two THE JOURNAL OF ANTIBIOTICS isomers, this evidence again suggests the f3-isomer for 2a. The rotations of 2a and 2b are, respectively, -22° and x-76° in H2O which would be consistent with a fl-configuration for 2a and an a configuration for 2b as the rotations of methyl 13-and a-D-glycopyranoside are -31.2° (H20) and + 158.2° (H20), respectively. While these data are not conclusive, the majority of the evidence favors assignment of the f3-form to 2a and of the a to 2b. The formation of these products probably involves an initial reduction to ld followed by cyclization. That such a cyclization could occur was shown by conversion of Id obtained by the procedure of HESSLER and JAHNKE13> to 2a simply by crystallization from ethanol.
Reduction of streptozotocin with a zinc-acetic acid mixture gave a new product (3) . Mass spectral and analytical data establish a molecular formula of C8H16N3O5. The it spectrum has a strong band carbon atom of the methyl group has a chemical shift of 8 37.4. The only remaining carbon gives a signal at 8 141.1 and therefore cannot be anomeric but must be the original C-I converted to a doubly bonded carbon as in 3. All of these data are consistent with structure 3. It seems probable that reduction of -NO to -NH2 (1c) occurs followed by cyclization to C-1. Ring opening follows under the influence of acid as has been shown to occur in the conversion of la to 4.12)
A second possible approach to the desired streptozotocin analogs would be acylation of a suitably protected glucosalnine derivative having a free amino group by an appropriate acylating agent. In order to prepare an analog (5) having a nitro group in the original nitroso position acylation was attempted with methyl N-nitro-N-methylcarbamate (eq. 1). However, the carbomethoxy group was NO, transferred rather than the CH3NCO moiety and the product was 6. The structure of the product is based on analysis, spectral data and synthesis from tetra-O-acetyl-2-deoxy-2-amino-a-D-glucopyranose and methyl chloroformate by the procedure of BROMUND and HERBST.1) The compound 6 but with no assignment of stereochemistry at C-I has been reported,16> but the product obtained by us differed in melting point and rotation from that of BROMUND and HERBST. The anomeric hydrogen has a coupling constant (J=4 Hz) which suggests the a isomer.'") It has been shown by MICHEEL, et a1.18> that tetra-0-acetyl-2-deoxy-2-amino-D-glucopyranose prepared according to the procedure of MOGGRIDGE and NEUBERGER1') (as was that used in these experiments) is the a-anomer as shown below and the previously reported compound") is the /3-isomer. Investigation of a simpler case of acylation with methyl Nnitro-N-methylcarbamate (eq. 2) also demonstrated carbomethoxy transfer. The next and successful approach to analog synthesis was the reaction of tetra-O-acetyl-2-deoxy-2-isocyanato-/3-D-glucopyranose (8) with compounds of the type CH3NHX (eq. 3). Compound 8 was prepared by the method of BERGMANN and ZERVAS2D) which has been shown to give the /3-isomer as indicated.181 Four analogs (9a, 9b, 9c and 9d) were prepared by this procedure. In the cases of 9a and 9b reaction was carried out in solvents, but in the other two cases the reactants were heated together at 85°C with no solvent. The products were identified by the usual spectral techniques and analyses. Elemental analyses of some of these compounds were not as close to theoretical values as desired and so were supplemented by high resolution mass spectrometry. Attempted conversion of compounds of type 9 to type 1 by ammonolysis failed when X = CH8CO but succeeded with X=C6H8 (9b--->Ie).
No conditions were found which would remove the 0-acetyl groups from 9d without removing the N-acetyl group. Reaction of methyl nitramine with 8 did not proceed by eq. 3 to give 9e but gave instead the /3- Table I and are expressed as ug/ml inhibiting growth of the cells by 50%. and 90%. As can be seen they are about as active as streptozotocin tetraacetate. In vivo tests against P388 leukemia in mice showed that all were inactive.
Experimental
Catalytic Reduction of Streptozotocin. A solution of 2.65 g (0.01 mole) of streptozotocin in 50 ml of 95'/,o/ EtOH was added to a mixture of I g of prereduced 10 % Pd-C and 100 ml of 95 % EtOH. The mixture was shaken for 5 hours at an initial pressure of 45 psi. In less than an hour about 0.01 mole of hydrogen had been absorbed and very little more reacted. Catalyst was removed by filtration, and the filtrate was concentrated to dryness under reduced pressure. Both 2a and 2b were prepared by the same procedure but in different experiments.
2a: One gram of the above residue was dissolved in EtOH, and the solution was filtered. After several days refrigeration at -15°C 340 mg of crystals precipitated. Recrystallization gave a nip of 171°C (lit. 
Tetra-O-acetyl-N-carb _omethoxy-2-deoxy-2-amino-x-D-glucopyranose (6). A. From Methyl N-nitro-N-methylcarbamate:
A solution of 210 mg (1.55 mmoles) of methyl N-nitro-N-methylcarbamate and 1.4 g (4 mmoles) of tera-O-acetyl-2-deoxy-2-amino-x-D-glucopyranose (MOGGRIDGE and NEUBERGER19') in 5 ml of dry DMSO was allowed to stand at room temperature for 6 days. The solution was diluted with 30 ml of water and extracted with three 25-m1 portions of CHCI3. The solvent was removed from the combined extracts by evaporation under reduced pressure, and the residue was chromatographed on 50 g of silica gel in cyclohexane-ethyl acetate-ethanol (5:4:1) and collecting one hundred and forty-seven 10-rill fractions. On the basis of a weight analysis fractions 6--14 were combined as pool 1 and fractions 16-29 were combined as pool 2. The two pools were evaporated under reduced pressure. The material from pool 2 was identified as starting glucosamine. 
2-Deo _x_y-2-(3-methyl-3-phenylureido)-/3-D-glucopyranose (Id).
Twelve grams of 9b was dissolved in 1.21iters of dry methanol containing 5 % NIla. The solution was allowed to stand at room temperature for 19 hours. The solvent and ammonia were removed by evaporation under reduced pressure at room temperature. The residue (19.2 g) was chromatographed on 450 g of silica using ethyl acetate -methanol -Skellysolve B (5: 1 : 4) and collecting three hundred and fifty-two 20-m1 fractions. The solvent mixture was changed to a ratio of 10: 3: 7 and 105 fractions were collected. On the basis of a weight analysis fractions 170.215 were combined as pool 1 and fractions 354~457 as pool 2. Evaporation of pool 1 under reduced pressure gave a product which was identified as acetamide by NMR. Evaporation of pool 2 under reduced pressure gave 4.75 g of residue which was chromatographed on 215 g of silica using ethyl acetate -methanol -Skellysolve B (10: 3 : 7). In each chromatography the material was dried down out of methanol onto silica and added to the top of the column. A total of one hundred and forty-seven 20-m1 fractions were collected. Fractions 81 ~ 120 were combined (wt. analysis) and evaporated under reduced pressure, yield 3.80 g (48 %), indefinite mp but homogeneous by tic (EtOAc -CH,OH -Skellysolve B; 5: 3 : 2); it (Nujol) 3450 (OH/NH) and 1655 (NCON) cm-'; uv (EtOH) max 238 nm (e 10,550); 'H NMR (de-DMSO) 8 
A mixture of 2.24 g (6 mmoles) of 8 and 0.41 g (7 mmoles) of N-methylformamide was heated at 85-90°C for 24 hours. The product was chromatographed three times on silica (about 50 g/g) using CHC13 -MeOH (9: 2) and collecting the first material which came off until it began to be contaminated by following material. This was followed by tic (CHCI, -MeOH; 95: 5 
